https://www.selleckchem.com/pr....oducts/Aloxistatin.h
Central venous occlusive disease (CVOD) is a prevalent problem in patients with end-stage renal disease (ESRD) and can lead to access malfunction or ligation for symptomatic relief. The purpose of this study is to evaluate the efficacy of the TriForce® Peripheral Crossing Set (Cook Medical), a novel reinforced telescoping catheter set designed to provide additional support for crossing difficult central venous occlusions. This is a single-center retrospective study from a quaternary referral center. We identified 37 patients over a
Like
Comment
Share
